No Absolute Contraindication to Dexamethasone in This Patient
A single dose of dexamethasone 10 mg IV is not contraindicated in this 40-year-old woman with WPW syndrome, as corticosteroids do not directly interact with cardiac conduction pathways or exacerbate pre-excitation syndromes. 1
WPW-Specific Considerations
The primary concern in WPW syndrome relates to antiarrhythmic medications that affect AV nodal conduction, not corticosteroids 1:
- Contraindicated drugs in WPW include AV nodal blockers (digoxin, verapamil, diltiazem, beta-blockers) when atrial fibrillation or flutter is present, as these can paradoxically accelerate conduction through the accessory pathway and precipitate ventricular fibrillation 1
- Dexamethasone has no direct cardiac electrophysiologic effects and does not block AV nodal conduction or affect accessory pathway function 2
- Since her ECG shows normal sinus rhythm (not atrial fibrillation/flutter), even the typical WPW drug contraindications are less relevant in this acute setting 1
Clinical Context Assessment
The key question is whether dexamethasone is clinically indicated, not whether it's contraindicated 1, 3:
Evidence Supporting Use:
- Streptococcal pharyngitis with systemic symptoms: A single dose of dexamethasone 10 mg has been used for symptomatic relief in severe pharyngitis, though evidence is limited 1, 4
- Suspected viral respiratory illness: If this represents influenza (despite negative test), dexamethasone may provide symptomatic benefit 1, 5
Evidence Against Routine Use:
- Clear chest X-ray argues against pneumonia, where corticosteroids might have a role 1, 3
- Bacterial pharyngitis alone does not have strong evidence supporting corticosteroid use 3
- Corticosteroids may mask infection signs and decrease resistance to new infections 2
Safety Profile for Single-Dose Dexamethasone
A single 10 mg dose carries minimal risk 4, 3, 5:
- No tapering required after single-dose or short-course (≤5 days) therapy 4, 3
- Adrenal suppression is not a concern with single-dose administration 2
- Common short-term effects include hyperglycemia (approximately 13 mg/dL increase within 12 hours) and sleep disturbances 3, 5
- Serious adverse effects (GI bleeding, perforation) are associated with high-dose prolonged therapy (≥96 mg/day), not single doses 3
Specific Contraindications to Screen For
Before administering dexamethasone, verify the patient does NOT have 3, 2:
- Active systemic fungal infection (absolute contraindication unless on antifungal prophylaxis) 3, 2
- Known hypersensitivity to dexamethasone or sulfites (the IV formulation contains sodium bisulfite) 2
- Active tuberculosis (unless on appropriate antituberculous therapy) 2
- Recent myocardial infarction (corticosteroids associated with increased risk of left ventricular free wall rupture) 2
Practical Recommendation
If you decide to give dexamethasone 10 mg IV 4, 3, 5:
- Monitor blood glucose if diabetic or at risk 3
- Counsel about sleep disturbance (common with evening/night dosing) 5
- Document clear indication (e.g., severe pharyngitis with systemic symptoms refractory to standard therapy) 1, 3
- Consider whether symptomatic treatment (NSAIDs, acetaminophen, adequate hydration) might be equally effective with fewer risks 1
Critical Caveat
The negative influenza test does not reliably rule out influenza, especially if tested outside the optimal window (first 3-4 days of illness) or if rapid antigen testing was used (sensitivity 50-70%) 1. However, one week into illness, influenza is less likely to be the primary driver of ongoing symptoms, and bacterial superinfection or post-viral inflammation becomes more relevant 1.
The WPW diagnosis itself poses no barrier to dexamethasone administration, but the clinical indication for corticosteroids in this presentation is questionable 1, 3.